As the most immunogenic subtype, TNBC exhibits high programmed death ligand 1 (PD-L1) expression, abundant tumor-infiltrating lymphocytes (TILs) [4], as well as genomic instability and a high mutation rate, which may lead to neoantigen production and increased immunogenicity [5, 6]. This evidence concerns the gene CD274 and neoplasm.